CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
The aim is to strengthen industry-academia cooperation
It plans to deliver over 300 million doses to the Indian government
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The trial will be conducted across 10 sites in India
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)